Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.96 +0.39 (+24.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nautilus Biotechnology (NAUT) Consolidated Net Income (2020 - 2026)

Updated

Nautilus Biotechnology (NAUT) posted Consolidated Net Income of -$15.76 million for Q2 2026, compared with -$17.1 million a year earlier.

Analysis

Nautilus Biotechnology (NAUT) Consolidated Net Income (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Nautilus Biotechnology was -$34.83 million; for FY2020, it came in at -$576,035.

  • The Q2 2026 figure stands as the highest quarterly Consolidated Net Income since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 1.74 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 928.00 Mn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 823.20 Mn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 377.00 Mn
10 Nautilus Biotechnology 249.36 Mn 249.36 Mn 175,000.00 -15.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.76 Mn
Jun 30, 2025 -17.10 Mn
Mar 31, 2021 -1.78 Mn
Sep 30, 2020 -174,671.00
API Access

Nautilus Biotechnology Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NAUT&period=max&api_key=YOUR_API_KEY